Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18982072rdf:typepubmed:Citationlld:pubmed
pubmed-article:18982072lifeskim:mentionsumls-concept:C0003864lld:lifeskim
pubmed-article:18982072lifeskim:mentionsumls-concept:C0442108lld:lifeskim
pubmed-article:18982072lifeskim:mentionsumls-concept:C0287186lld:lifeskim
pubmed-article:18982072lifeskim:mentionsumls-concept:C0004379lld:lifeskim
pubmed-article:18982072lifeskim:mentionsumls-concept:C0449258lld:lifeskim
pubmed-article:18982072lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:18982072lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:18982072lifeskim:mentionsumls-concept:C0441722lld:lifeskim
pubmed-article:18982072lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:18982072lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:18982072lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:18982072pubmed:issue11lld:pubmed
pubmed-article:18982072pubmed:dateCreated2008-11-4lld:pubmed
pubmed-article:18982072pubmed:abstractTextOne of the hallmarks of rheumatoid arthritis (RA) is hyperplasia and inflammation of the synovial tissue being characterized by in situ occurrence of highly differentiated leukocytes. Fms-like tyrosine kinase 3 (Flt3) has a crucial role in hematopoiesis, regulation of cell proliferation, differentiation and apoptosis. Typically, Flt3 is expressed on early myeloid and lymphoid progenitors and is activated by its soluble ligand (Flt3-L). The highly differentiated cellular pattern in the synovium of the RA patients made us hypothesize that Flt3-L, with its ability to induce proliferation and differentiation, could be of importance in induction and/or progression of arthritis.lld:pubmed
pubmed-article:18982072pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:languageenglld:pubmed
pubmed-article:18982072pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:citationSubsetIMlld:pubmed
pubmed-article:18982072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982072pubmed:statusMEDLINElld:pubmed
pubmed-article:18982072pubmed:issn1932-6203lld:pubmed
pubmed-article:18982072pubmed:authorpubmed-author:MagnussonMatt...lld:pubmed
pubmed-article:18982072pubmed:authorpubmed-author:TarkowskiAndr...lld:pubmed
pubmed-article:18982072pubmed:authorpubmed-author:FosterSimon...lld:pubmed
pubmed-article:18982072pubmed:authorpubmed-author:RottapelRober...lld:pubmed
pubmed-article:18982072pubmed:authorpubmed-author:BokarewaMaria...lld:pubmed
pubmed-article:18982072pubmed:authorpubmed-author:DahlbergLeif...lld:pubmed
pubmed-article:18982072pubmed:authorpubmed-author:DehlinMatsMlld:pubmed
pubmed-article:18982072pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18982072pubmed:volume3lld:pubmed
pubmed-article:18982072pubmed:ownerNLMlld:pubmed
pubmed-article:18982072pubmed:authorsCompleteYlld:pubmed
pubmed-article:18982072pubmed:paginatione3633lld:pubmed
pubmed-article:18982072pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:meshHeadingpubmed-meshheading:18982072...lld:pubmed
pubmed-article:18982072pubmed:year2008lld:pubmed
pubmed-article:18982072pubmed:articleTitleIntra-articular fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis.lld:pubmed
pubmed-article:18982072pubmed:affiliationDepartment of Rheumatology and Inflammation Research, Göteborg University, Göteborg, Sweden. mats.dehlin@vgregion.selld:pubmed
pubmed-article:18982072pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18982072pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2323entrezgene:pubmedpubmed-article:18982072lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18982072lld:entrezgene
lhgdn:association:32637lhgdn:found_inpubmed-article:18982072lld:lhgdn
lhgdn:association:32643lhgdn:found_inpubmed-article:18982072lld:lhgdn